NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Elon Musk's Tesla Sued, 'Black Swan' Author Calls Bitcoin Tumor, FDA Okays Most-Expensive Drug And More: 5 Key Stories You May Have Missed From The Weekend

Published 19/09/2022, 14:01
© Reuters.  Elon Musk's Tesla Sued, 'Black Swan' Author Calls Bitcoin Tumor, FDA Okays Most-Expensive Drug And More: 5 Key Stories You May Have Missed From The Weekend
CMCSA
-
TSLA
-
IXIC
-
BTC/EUR
-
BTC/USD
-
CMCS34
-
KECR
-
BTC/EUR
-
BTC/JPY
-
BTC/USD
-
BTC/JPY
-
BTC/GBP
-
BTC/GBP
-

As the market looks ahead to the Federal Open Market Committee meeting, discussions over the weekend centered around the Fed decision and its implication for growth and the financial markets.

Here's a recap of a few major headlines that hit the wire over the weekend:

Black Swan Author Slams Fed, Bitcoin: Nassim Taleb renewed his Bitcoin (CRYPTO: BTC) bashing and also criticized the Fed for maintaining interest rates at extremely accommodative levels. “Zero interest rate for a long period of time, you are hurting the economy, you are creating a bubble, creating tumors like Bitcoin,” he said. He renewed his call for the apex crypto going as low as 0.

Disney-Comcast Lock Horns Over Hulu: Streaming platform Hulu is majority owned by Walt Disney Company (NYSE: NYSE:DIS), while Comcast Corporation (NYSE: NASDAQ:CMCSA) holds a 33% stake in the platform. Both companies have a deal in place to transfer full ownership in Hulu to Disney in 2024.

Disney’s CEO Bob Chapek has recently sounded out his intention to push forward the timeline for the acquisition of the remaining stake in Hulu. While Chapek suggested a lower price could be renegotiated, Comcast CEO Brian Roberts ruled out any such move.

Tesla Sued Over Deceptive FSD Advertising: A Tesla Inc. (NASDAQ: NASDAQ:TSLA) owner has sued the company and its CEO Elon Musk for deceptively advertising the full-self driving software tech as fully functioning or “just around the corner” despite knowing that it did not work or was non-existent and made vehicles unsafe. He had reportedly paid a $5,000 premium for his 2018 Model X to get “Enhanced Autopilot,” which was sold as a precursor to the FSD software suite.

Bluebird bio Receives Back-to-Back Nod: bluebird bio Inc. (NASDAQ: BLUE) announced that the FDA approved its gene therapy to treat a rare, inherited neurodegenerative condition called cerebral adrenoleukodystrophy, which affects young boys, between the ages of 4 and 17 years. The wholesale price of the drug is fixed at $3 million, making it the most expensive drug to date.

Elon Musk Gets Pat On The Back: Tesla CEO Elon Musk received praises from Eric Schmidt, who formerly served as Alphabet Inc. (NASDAQ: NASDAQ:GOOGL) (NASDAQ: GOOG) unit Google’s chairman and CEO, for providing Ukraine with SpaceX’s Starlink terminals.

“Elon is a real hero in the story,” he reportedly said, praising him for the speed of the internet Starlink provided while he was traveling by train in Ukraine.

What Else: U.S. President Joe Biden signaled that he isn’t yet decided on running for office in 2024. It’s an intention to run again, he said, adding that it remains to be seen whether it is a firm decision to run.

Russian President Vladimir Putin said if Europe wants more gas, it should lift sanctions on the Nord Stream 2 pipeline. He denied Russia’s role in Europe’s current energy crisis and blamed the predicament on the continent’s “green agenda.”

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.